Regenxbio (RGNX) Prepaid Assets (2014 - 2025)
Regenxbio (RGNX) recorded quarterly Prepaid Assets of $12.9 million in Q4 2025, down 33.73% quarter-over-quarter from $19.5 million in Q3 2025, and up 42.33% on a YoY basis from $9.1 million in Q4 2024.
Regenxbio (RGNX) Prepaid Assets (2014 - 2025) Analysis & Trends
Regenxbio's Prepaid Assets history runs 12 years deep, the most recent figure standing at $12.9 million for Q4 2025.
- In Q4 2025, Prepaid Assets rose 42.33% year-over-year to $12.9 million; the TTM figure through Dec 2025 stood at $12.9 million (up 42.33% YoY), while the FY2025 annual figure was $12.9 million, up 42.33% from the prior year.
- Prepaid Assets was $12.9 million for Q4 2025 at Regenxbio, down from $19.5 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $23.5 million in Q2 2024 to a low of $2.9 million in Q1 2021.
- Historically, Prepaid Assets has averaged $14.1 million across 5 years, with a median of $14.7 million in 2022.
- Biggest YoY gain for Prepaid Assets was 422.07% in 2021; the steepest drop was 59.04% in 2021.
- A 5-year view of Prepaid Assets shows it stood at $10.2 million in 2021, then declined by 8.28% to $9.4 million in 2022, then soared by 55.26% to $14.5 million in 2023, then slumped by 37.56% to $9.1 million in 2024, then soared by 42.33% to $12.9 million in 2025.
- The last three Prepaid Assets figures came in at $12.9 million (Q4 2025), $19.5 million (Q3 2025), and $10.8 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Regenxbio | 315.11 Mn | 85.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 12.91 Mn |
| Sep 30, 2025 | 19.47 Mn |
| Jun 30, 2025 | 10.78 Mn |
| Mar 31, 2025 | 16.08 Mn |
| Dec 31, 2024 | 9.07 Mn |
| Sep 30, 2024 | 16.08 Mn |
| Jun 30, 2024 | 23.50 Mn |
| Mar 31, 2024 | 13.59 Mn |
| Dec 31, 2023 | 14.52 Mn |
| Sep 30, 2023 | 23.35 Mn |
| Jun 30, 2023 | 15.11 Mn |
| Mar 31, 2023 | 15.52 Mn |
| Dec 31, 2022 | 9.35 Mn |
| Sep 30, 2022 | 14.82 Mn |
| Jun 30, 2022 | 16.25 Mn |
| Mar 31, 2022 | 7.18 Mn |
| Dec 31, 2021 | 10.20 Mn |
| Sep 30, 2021 | 18.40 Mn |
| Jun 30, 2021 | 13.09 Mn |
| Mar 31, 2021 | 2.88 Mn |